trial

Hippotherapy in Patients With Schizophrenia

NCTId NCT06303596
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 88 (estimated)
Sponsored by Erzurum Technical University
Primary completion 2024-08-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
88 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2024-03-20
Primary completion
2024-08-01
Eligibility
ALL · 19 Years

Interventions & indications

Drugs
HippotherapyStandard Psychiatric Treatment

Sponsors

Erzurum Technical UniversityLead Sponsor

Investigators

5
Zeynep Oztürk, Ph.D., Assist. Prof.Study Director
Nurgül Karakurt, Ph.D., Assist. Prof.Principal Investigator
Elif O Tozoğlu, M.D.Principal Investigator
Musa Eymir, Ph.D., PT, Assist. Prof.Principal Investigator
Serdar UlusoyPrincipal Investigator

Sites

1 total
Erzurum, Turkey (Türkiye)

Facts & assertions

4 sourced
Enrollment
88
Phase
NA
Primary Completion Date
2024-08-01
Status
UNKNOWN
relationships
The graph out of here
drug
Hippotherapy
drug
Standard Psychiatric Treatment
drug
lead_sponsor
Erzurum Technical University
company
indication
Schizophrenia
indication
Schizophrenia
indication
Anxiety Disorders
indication
investigator
Zeynep Oztürk, Ph.D., Assist. Prof.
person
Nurgül Karakurt, Ph.D., Assist. Prof.
person
Elif O Tozoğlu, M.D.
person
Musa Eymir, Ph.D., PT, Assist. Prof.
person